Cassava Sciences, Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
SAVA Company Description
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
SAVA Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view SAVA Smart Score
Score Breakdown
SAVA Company Description
Show More
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of SAVA by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by SAVA's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on SAVA's company Twitter account
WallStreetBets
Number of mentions of SAVA in WallStreetBets Daily Discussion
SAVA News
Recent insights relating to SAVA
CNBC Recommendations
Recent picks made for SAVA stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in SAVA
Corporate Flights
Flights by private jets registered to SAVA
Our Analysis